Vitamin D Supplementation in Patients With Type 2 Diabetes: The Vitamin D for Established Type 2 Diabetes (DDM2) Study
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Observational data support a role for vitamin D in type 2 diabetes, but evidence from trials is inconclusive. To evaluate the effect of vitamin D supplementation on β-cell function and hemoglobin A1c (HbA1c) in patients with well-controlled type 2 diabetes. Double-blind, randomized, placebo-controlled clinical trial. Tufts Medical Center, Boston, MA; VA Medical Center, Cincinnati, OH. A total of 127 patients (mean age, 60 years) with stable (HbA1c ≤7.5%) diabetes managed with lifestyle only or lifestyle plus metformin. Subjects were given 4000 units of vitamin D3 (cholecalciferol) daily or placebo for 48 weeks. Insulin secretion rate (ISR) was estimated from peripheral plasma C-peptide levels after a 3-hour 75-g oral glucose tolerance test done at baseline and week 24. Changes in HbA1c were assessed at 16, 24, 36, and 48 weeks. Baseline mean plasma 25-hydroxyvitamin D [25(OH)D] concentration was 26.6 ng/mL, mean HbA1c was 6.6%, and 78% of patients were on metformin. At week 24, mean 25(OH)D changed by 20.5 and −1.6 ng/mL in the vitamin D and placebo groups, respectively (P < 0.001). The vitamin D and placebo groups did not differ in change in ISR or HbA1c. Among patients treated with lifestyle only (n = 28), vitamin D supplementation reduced HbA1c compared with placebo (−0.1% vs 0.3%, respectively; P = 0.034) at week 24. This result was not observed at the other time points and could be due to chance. Vitamin D3 at 4000 IU/d did not change ISR or HbA1c in patients with well-controlled type 2 diabetes on metformin not selected for vitamin D deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feskanich, D., Rimm, E. B., Giovannucci, E. L., Colditz, G. A., Stampfer, M. J., Litin, L. B., & Willett, W. C. (1993) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(93)91754-e · Cited by 1,070 · cited 1×
“A food frequency questionnaire was completed at baseline [15, 16].”
BackgroundFerrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1133 · Cited by 540 · cited 1×
“The primary endpoint was change from baseline to 24 weeks in insulin secretion rate (ISR), estimated from glucose and C-peptide from the OGTT by deconvolution analysis using a twocompartmentmodel with standard parameters for C-peptide kinetics [17, 18].”
MethodSelf-citationMitri, J., & Pittas, A. G. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.010 · Cited by 258
PATEL, P., PORETSKY, L., & LIAO, E. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00057.x · Cited by 73
SORIC, M. M., RENNER, E. T., & SMITH, S. R. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00164.x · Cited by 52 · cited 2×
“[9] randomized 37 patients with type 2 diabetes (baseline HbA1c, 8.”
BackgroundMethod
Cited by
Xing, C., Zhang, J., Zhao, H., & He, B. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s344542 · Cited by 118
Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review
Menichini, D., & Facchinetti, F. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1625881 · Cited by 73
“expression, as well suppressing proinflammatory cytokines [13].”
Sarahian, N., Sarvazad, H., Sajadi, E., Rahnejat, N., & Eskandari Roozbahani, N. (2021) · Reproductive Health · doi:10.1186/s12978-021-01203-x · Cited by 30
Metadata
- Authors
- Angellotti, E., D’Alessio, D., Dawson-Hughes, B., Nelson, J., Cohen, R. M., Gastaldelli, A., & Pittas, A. G.
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2018-02-26
- Volume
- 2
- Issue
- 4
- Pages
- 310-321
- ISSN
- 2472-1972 (ISSN-L)
- OpenAlex
- W2791407894
- Cited by
- 42
- References
- 5
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.